Third party contract manufacturing Sterile Injectables (Vials and Ampoules), Topicals and Ophthalmics / Otics (Ointments, Creams and Liquids) including liquid and lyophilized (freeze-dried) injectables Non-Sterile, Semi-Solid and Solid Dose ointment, Creams, liquids and solid Dose formats including tablets, caplets and capsules
| Website | http://www.draxis.com |
| Revenue | $25 million |
| Employees | 50 (26 on RocketReach) |
| Founded | 1987 |
| Address | 6870 Goreway Dr. Ste. 200, Mississauga, Ontario L4V 1P1, CA |
| Phone | (905) 677-5500 |
| Technologies | |
| Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Manufacturing, Pharmaceuticals, Pharmaceutical, Healthcare, Health Care |
| Keywords | Pharmaceutical Contract Manufacturing, Contract Manufacturing Services, Sterile Injectables, Cdmo, Drug Manufacturing, Pharmaceutical Manufacturing, Topical Ointments, Cream Manufacturing, Liquid Injectables, Custom Pharmaceutical Manufacturing, Cgmp Manufacturing, Semi-Solid Dosage Forms |
| Competitors | Roche, Pfizer, Amgen, Bristol Myers Squibb, Teva Pharmaceuticals, Johnson & Johnson, Novo Nordisk, Sandoz, Merck AH, Mylan Belgium +53 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 2834 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Draxis Pharma employee's phone or email?
The Draxis Pharma annual revenue was $25 million in 2026.
Rachel Duguay is the Director Quality Operations of Draxis Pharma.
26 people are employed at Draxis Pharma.
Draxis Pharma is based in Mississauga, Ontario.
The NAICS codes for Draxis Pharma are [325, 32, 32541, 3254].
The SIC codes for Draxis Pharma are [28, 283, 2834].